Liver disease in cystic fibrosis

dc.creatorTombazzi,Claudio R
dc.creatorRiely,Caroline A
dc.date2001-09-01
dc.date.accessioned2017-03-07T15:33:14Z
dc.date.available2017-03-07T15:33:14Z
dc.identifierhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000900015
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/387094
dc.descriptionBecause of improved survival in the past two decades, liver disease has assumed greater importance in patients with cystic fibrosis. Clinical detection has been difficult thus far. In recent years, advances in our understanding of pathogenesis as well as increasing experience in therapeutic modalities have been accomplished. For these reasons, it is relevant to review this topic (Rev Med Chile 2001; 129: 1071-8)
dc.formattext/html
dc.languageen
dc.publisherSociedad Médica de Santiago
dc.sourceRevista médica de Chile v.129 n.9 2001
dc.subjectCholestasis, intrahepatic
dc.subjectCystic Fibrosis
dc.subjectCystic Fibrosis transmembrane regulator
dc.subjectLiver diseases
dc.subjectUrsodeoxycholic acid
dc.titleLiver disease in cystic fibrosis
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución